4//SEC Filing
Parkinson David Ross 4
Accession 0001209191-22-054970
CIK 0001633932other
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 11:06 AM ET
Size
12.3 KB
Accession
0001209191-22-054970
Insider Transaction Report
Form 4
ESSA Pharma Inc.EPIX
Parkinson David Ross
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2022-06-29+222,500→ 222,500 totalExercise: $3.60Exp: 2032-06-29→ Common Shares (222,500 underlying)
Footnotes (1)
- [F1]One-fourth vests after 12 months from the date of grant with the remaining three-fourths vesting in 36 equal installments with the first installment vesting at the end of the 13th month and subsequent installments vesting every one month anniversary thereafter.
Issuer
ESSA Pharma Inc.
CIK 0001633932
Entity typeother
Related Parties
1- filerCIK 0001451935
Filing Metadata
- Form type
- 4
- Filed
- Oct 31, 8:00 PM ET
- Accepted
- Nov 1, 11:06 AM ET
- Size
- 12.3 KB